Skip to content

ROCK CREEK PHARMACEUTICALS, INC.: stockholders equity

Stockholders equity for ROCK CREEK PHARMACEUTICALS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.

All ROCK CREEK PHARMACEUTICALS, INC. financial histories

What this measure means

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Exact concept: us-gaap:StockholdersEquity. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2008-12-31 to 2015-12-31. The SEC response was captured on 2026-09-22.

This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.

Selected filing history

Stockholders equity in original reported units, latest-filed observation per period
Period startPeriod endValueUnitFiledSource filing
-2015-12-31-10,646,000USD2016-03-2210-K · 0001144204-16-089559 SEC
-2014-12-31-10,835,000USD2016-03-2210-K · 0001144204-16-089559 SEC
-2013-12-316,979,000USD2016-03-2210-K · 0001144204-16-089559 SEC
-2012-12-3124,984,000USD2015-03-1210-K · 0001144204-15-015687 SEC
-2011-12-319,391,000USD2015-03-1210-K · 0001144204-15-015687 SEC
-2010-12-3110,659,000USD2014-03-1710-K · 0001144204-14-016079 SEC
-2009-12-312,288,000USD2013-03-1810-K · 0001144204-13-015866 SEC
-2008-12-31-498,000USD2012-03-1510-K · 0001193125-12-117380 SEC

Related ROCK CREEK PHARMACEUTICALS, INC. histories

Inspect the source

Entity
ROCK CREEK PHARMACEUTICALS, INC. / CIK 0000776008
Captured
SEC response SHA-256
def6ed06654a559060739a2bd8ba4a10d08e6c32c76c99acbcccf3c1f30c674d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000776008.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))